304 related articles for article (PubMed ID: 35579806)
1. Artificial Intelligence in Pharmacovigilance: An Introduction to Terms, Concepts, Applications, and Limitations.
Aronson JK
Drug Saf; 2022 May; 45(5):407-418. PubMed ID: 35579806
[TBL] [Abstract][Full Text] [Related]
2. Artificial Intelligence and the Future of the Drug Safety Professional.
Danysz K; Cicirello S; Mingle E; Assuncao B; Tetarenko N; Mockute R; Abatemarco D; Widdowson M; Desai S
Drug Saf; 2019 Apr; 42(4):491-497. PubMed ID: 30343417
[TBL] [Abstract][Full Text] [Related]
3. Pharmacovigilance from social media: mining adverse drug reaction mentions using sequence labeling with word embedding cluster features.
Nikfarjam A; Sarker A; O'Connor K; Ginn R; Gonzalez G
J Am Med Inform Assoc; 2015 May; 22(3):671-81. PubMed ID: 25755127
[TBL] [Abstract][Full Text] [Related]
4. Portable automatic text classification for adverse drug reaction detection via multi-corpus training.
Sarker A; Gonzalez G
J Biomed Inform; 2015 Feb; 53():196-207. PubMed ID: 25451103
[TBL] [Abstract][Full Text] [Related]
5. Validation of Artificial Intelligence to Support the Automatic Coding of Patient Adverse Drug Reaction Reports, Using Nationwide Pharmacovigilance Data.
Martin GL; Jouganous J; Savidan R; Bellec A; Goehrs C; Benkebil M; Miremont G; Micallef J; Salvo F; Pariente A; Létinier L;
Drug Saf; 2022 May; 45(5):535-548. PubMed ID: 35579816
[TBL] [Abstract][Full Text] [Related]
6. Artificial Intelligence Within Pharmacovigilance: A Means to Identify Cognitive Services and the Framework for Their Validation.
Mockute R; Desai S; Perera S; Assuncao B; Danysz K; Tetarenko N; Gaddam D; Abatemarco D; Widdowson M; Beauchamp S; Cicirello S; Mingle E
Pharmaceut Med; 2019 Apr; 33(2):109-120. PubMed ID: 31933254
[TBL] [Abstract][Full Text] [Related]
7. From narrative descriptions to MedDRA: automagically encoding adverse drug reactions.
Combi C; Zorzi M; Pozzani G; Moretti U; Arzenton E
J Biomed Inform; 2018 Aug; 84():184-199. PubMed ID: 29981491
[TBL] [Abstract][Full Text] [Related]
8. Machine learning in medicine: what clinicians should know.
Ting Sim JZ; Fong QW; Huang W; Tan CH
Singapore Med J; 2023 Feb; 64(2):91-97. PubMed ID: 34005847
[TBL] [Abstract][Full Text] [Related]
9. The Use of Artificial Intelligence in Pharmacovigilance: A Systematic Review of the Literature.
Salas M; Petracek J; Yalamanchili P; Aimer O; Kasthuril D; Dhingra S; Junaid T; Bostic T
Pharmaceut Med; 2022 Oct; 36(5):295-306. PubMed ID: 35904529
[TBL] [Abstract][Full Text] [Related]
10. Artificial Intelligent Context-Aware Machine-Learning Tool to Detect Adverse Drug Events from Social Media Platforms.
Roosan D; Law AV; Roosan MR; Li Y
J Med Toxicol; 2022 Oct; 18(4):311-320. PubMed ID: 36097239
[TBL] [Abstract][Full Text] [Related]
11. Artificial Intelligence and Data Mining for the Pharmacovigilance of Drug-Drug Interactions.
Hauben M
Clin Ther; 2023 Feb; 45(2):117-133. PubMed ID: 36732152
[TBL] [Abstract][Full Text] [Related]
12. Making Sense of Pharmacovigilance and Drug Adverse Event Reporting: Comparative Similarity Association Analysis Using AI Machine Learning Algorithms in Dogs and Cats.
Xu X; Mazloom R; Goligerdian A; Staley J; Amini M; Wyckoff GJ; Riviere J; Jaberi-Douraki M
Top Companion Anim Med; 2019 Dec; 37():100366. PubMed ID: 31837760
[TBL] [Abstract][Full Text] [Related]
13. Artificial Intelligence and Machine Learning in Pharmacological Research: Bridging the Gap Between Data and Drug Discovery.
Singh S; Kumar R; Payra S; Singh SK
Cureus; 2023 Aug; 15(8):e44359. PubMed ID: 37779744
[TBL] [Abstract][Full Text] [Related]
14. Trust but Verify: Lessons Learned for the Application of AI to Case-Based Clinical Decision-Making From Postmarketing Drug Safety Assessment at the US Food and Drug Administration.
Ball R; Talal AH; Dang O; Muñoz M; Markatou M
J Med Internet Res; 2024 Jun; 26():e50274. PubMed ID: 38842929
[TBL] [Abstract][Full Text] [Related]
15. What place for intelligent automation and artificial intelligence to preserve and strengthen vigilance expertise in the face of increasing declarations?
Pariente A; Micallef J; Lahouegue A; Molimard M; Auffret M; Chouchana L; Denis B; Faillie JL; Grandvuillemin A; Letinier L; Pierron E; Pons C; Pujade I; Rubino H; Salvo F
Therapie; 2023; 78(1):131-143. PubMed ID: 36572627
[TBL] [Abstract][Full Text] [Related]
16. Intelligent Telehealth in Pharmacovigilance: A Future Perspective.
Edrees H; Song W; Syrowatka A; Simona A; Amato MG; Bates DW
Drug Saf; 2022 May; 45(5):449-458. PubMed ID: 35579810
[TBL] [Abstract][Full Text] [Related]
17. Introduction to The Spine Journal special issue on artificial intelligence and machine learning.
Karhade AV; Schwab JH
Spine J; 2021 Oct; 21(10):1601-1603. PubMed ID: 33785475
[TBL] [Abstract][Full Text] [Related]
18. "Artificial Intelligence" for Pharmacovigilance: Ready for Prime Time?
Ball R; Dal Pan G
Drug Saf; 2022 May; 45(5):429-438. PubMed ID: 35579808
[TBL] [Abstract][Full Text] [Related]
19. Will the future of pharmacovigilance be more automated?
Salvo F; Micallef J; Lahouegue A; Chouchana L; Létinier L; Faillie JL; Pariente A
Expert Opin Drug Saf; 2023; 22(7):541-548. PubMed ID: 37435796
[TBL] [Abstract][Full Text] [Related]
20. A primer on applying AI synergistically with domain expertise to oncology.
Kim J; Kusko R; Zeskind B; Zhang J; Escalante-Chong R
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188548. PubMed ID: 33901609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
